j) Provisions and Contingencies

a. Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, itis probable that an
outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount
of the obligation. When the Company expects some or all of a provision to be reimbursed, for example, under an insurance contract, the
reimbursement is recognised as a separate asset, but only when the reimbursement is virtually certain. The expense relating to a provision is
presented in the statement of profit and loss net of any reimbursement.

If the effect of the time value of money is material, provisions are discounted using a current pre-tax rate that reflects, when appropriate, the
risks specific to the liability.When discounting is used, the increase in the provision due to the passage of time is recognised as a finance cost.

b. Contingent Liabilities and Contingent Assets

A contingent liability is a possible obligation that arises from a past event, with the resolution of the contingency dependent on uncertain future
events, or a present obligation where no outflow is probable. Major contingent liabilities are disclosed in the financial statements unless the
possibility of an outflow of economic resources is remote. Contingent assets are not recognized in the standalone financial statements but
disclosed, where an inflow of economic benefit is probable.

k) Cash and cash equivalents

Cash comprises cash on hand and demand deposits with banks. Cash equivalents are short-term balances (with an original maturity of three months
or less from the date of acquisition), highly liquid investments that are readily convertible into known amounts of cash and which are subject to
insignificant risk of changes in value.

l) Statement of cash flows

Cash flows are reported using the indirect method, whereby net profit before tax is adjusted for the effects of transactions of a non-cash nature and
any deferrals or accruals of past or future cash receipts or payments.The cash flows from operating, investing and financing activities of the Company
are segregated.

66 Additional Regulatory Information

(i) The title deeds of all the immovable properties (other than properties where the Company is the lessee and the lease agreements are duly
executed in favour of the lessee), as disclosed under Property, Plant and Equipment in the financial statements are held in the name of the
Company.

(ii) There are no proceedings that have been initiated or pending against the Company for holding any any benami property under the Benami
Transactions (Prohibitions) Act, 1988 (45 of 1988) and the Rules made thereunder.

(iii) The Company has not been declared as a wilful defaulter by any bank or financial institution or any other lender

(iv) The Company has no transactions with companies struck off under section 248 of the Companies Act, 2013 or section 560 of the Companies
Act, 1956.

(v) The details of charges and satisfaction of charges have been registered with Registrar of Companies within the statutory period

(vi) Utilisation of Borrowed Funds and Share premium

(A) The Company has not advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds) by
the Company to or in any other person(s) or entity(ies), including foreign entities (“Intermediaries”) with the understanding, whether recorded
in writing or otherwise, that the Intermediary shall lend or invest in party identified by or on behalf of the Company (Ultimate Beneficiaries).

(B) The Company has not received any fund from any party(s) (Funding Party) with the understanding that the Company shall whether, directly or
indirectly lend or invest in other persons or entities identified by or on behalf of the Company ("Ultimate Beneficiaries”) or provide any
guarantee, security or the like on behalf of the Ultimate Beneficiaries.

(vii) The Company declares that the Relevant Provisions of the FEMA Act ,1999 and Companies Act have been Complied with and are not in
violation of the Prevention of Money-Laundering Act ,2002.

(viii) The Company does not have any such transaction which is not recorded in the books of accounts that has been surrendered or disclosed as
income during the year in the tax assessments under the Income Tax Act, 1961 (such as, search or survey or any other relevant provisions of the
IncomeTaxAct, 1961

(ix) The Company has not traded or invested in Crypto currency orVirtual Currency during the financial year.

As per our report of even date attached for and on behalf of the board of directors of

for S S J N B & CO Bal Pharma Limited

Chartered Accountants

Firm registration number: 0I3976S

Shailesh Siroya V Himesh

Dhanpal I Sakaria Managing Director Whole Time Director

Partner DIN: 00048109 DIN: 08554422

Membership No: 213666

Place: Bengaluru Bharath Bhushan D.V ^{Abdul Basith}

Date : 29th May, 2025 Chief Financial Officer ^Comp^any ^Secretary

UDIN: 252I3666BMNZIK5462 Place: Bengaluru

Date: 29th May, 2025